13F

Stock

Keros Therapeutics, Inc.

KROS · held by 8 managers

Reported value

$11.7M

Holders

8

+0 new · −0 exited

Holders’ est. mark

$245.1K

Price effect on 2 books still in the name

Largest holder

$6.25M

MORGAN STANLEY

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
MORGAN STANLEY395.1K$6.25MHeld
BANK OF AMERICA CORP /DE/226.1K$3.58MHeld
BARCLAYS PLC99.1K$1.57M$244.8KCut−$49.3K
TUDOR INVESTMENT CORP ET AL19.5K$308.9KHeld
Essential Partners LLC942$14.9K$323Added$13.2K
Allworth Financial LP662$10.5KHeld
IFP Advisors, Inc29$459Held
FNY Investment Advisers, LLC2.5K$39Held

Positions as of Q3 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.